Of the menaquinones which form vitamin K2, menaquinone-7 is the fraction with the highest bioavailability and activity. Menaquinone has been used in Japan since 1995 to prevent osteoporosis and in particular, to prevent fractures of the hip.
¤ Research shows that menaquinone-7 regulates production of calcium :
it activates a specific protein which optimises the binding of calcium to the bone structure essential for bone density, thus preventing the development of osteoporosis ;
in blood vessels, it activates a protein which prevents calcium from being deposited in artery walls. By preventing calcification and hardening of the arteries, it exerts a protective effect against cardiovascular disease.
¤ The addition of vitamin D3 significantly boosts the action of menaquinone-7, particularly in the prevention of osteoporosis.
Each softgel contains 30 mg Nattoesse™ MK-7 providing 45 mcg menaquinone 7, the most active and bioavailable form of vitamin K2.
It also contains 200 IU of vitamin D3. When taken together, menaquinone 7 and vitamin D3 act synergistically, significantly boosting their efficacy.
Take two softgels a day, with your two main meals.
Warning - do not take this product with anticoagulants.
Precautions: Do not exceed the recommended daily dose. This product is a nutritional supplement and should not replace a varied, balanced diet. Keep out of childrens' reach. Store away from direct light, heat and humidity. As with any nutritional supplement, you should consult a health professional before taking this product if you are pregnant, breastfeeding or have a health problem.
Call us :
+352 264 _955 25
From 10am to 7pm
Newsletter
Keep up to date with Supersmart's new products and special offers, as well as news of the latest scientific research, delivered straight to your Inbox
The wish list lets you save items you're interested in so you can add them to your basket easily the next time you visit the site. You need to be registered to use this service.